Skip to main content
Vitrolife logo

Vitrolife — Investor Relations & Filings

Ticker · VITR ISIN · SE0011205202 LEI · 5493001WDZMONMSPPR49 ST Manufacturing
Open in API
Filings indexed 656 across all filing types
Latest filing 2009-04-21 Report Publication Anno…
Country SE Sweden
Listing ST VITR

About Vitrolife

https://www.vitrolife.com/

Vitrolife is a global company focused on reproductive health, providing medical devices and genetic testing services primarily to In Vitro Fertilization (IVF) clinics. The company develops, produces, and markets a comprehensive portfolio of products and solutions that support the entire assisted reproduction treatment journey, from oocyte retrieval and sperm preparation to fertilization, embryo culture, evaluation, transfer, and cryopreservation. With a strong emphasis on quality control, innovation, and clinical support, Vitrolife aims to improve treatment outcomes and operational efficiency for its partners. The company also offers educational resources and training for professionals through its Vitrolife Academy.

Recent filings

Filing Released Lang Actions
Report Publication Announcement 2009
Report Publication Announcement Classification · 99% confidence The document is an invitation for a conference call regarding the interim report ('delårsrapporten') for January-March 2009. It explicitly states that the press release containing the interim report will be published on April 27th, and the conference call is scheduled for April 28th. The document itself is not the full interim report (IR) or the earnings release (ER), but rather an announcement about the upcoming release of the report and the associated conference call details. Since the primary purpose is to announce the publication of a report and provide details for accessing related materials (conference call, presentation slides), it fits the definition of a Report Publication Announcement (RPA). The document length (2850 chars) is short, supporting the 'MENU VS MEAL' rule, as it is announcing the report rather than containing the full financial details.
2009-04-21 Swedish
Major Shareholding Notification 2009
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage for SEB Investment Management AB concerning Vitrolife AB. Specifically, it shows the 'Before the transaction' and 'After the transaction' share counts, the reason for the notification ('Sell'), and the resulting percentage (dropping below the 5% limit). This structure—reporting changes in significant ownership thresholds—is characteristic of a Major Shareholding Notification. This aligns with the definition for 'Major Shareholding Notification' (Code: MRQ). The document is short and contains the final data, not an announcement of a report.
2009-04-09 English
Annual Report 2008
Annual Report Classification · 100% confidence The document is titled 'Årsredovisning 2008' (Annual Report 2008) for Vitrolife AB. It contains a comprehensive overview of the company's activities, financial statements (balance sheets, income statements, cash flow), management reports, and audit information for the full fiscal year 2008. It is clearly the primary annual report document, not an announcement or summary. FY 2008
2009-04-03 Swedish
Annual Report 2008
Annual Report Classification · 100% confidence The document is titled 'Årsredovisning 2008' (Annual Report 2008) for Vitrolife AB. It contains a comprehensive overview of the company's activities, financial statements (balance sheets, income statements, cash flow), management reports, and audit information for the full fiscal year 2008. It is clearly the primary annual report document, not an announcement or summary. FY 2008
2009-04-03 English
Regulatory Filings 2009
Regulatory Filings Classification · 95% confidence The document is a short press release dated April 1, 2009, announcing a strategic business decision: establishing a sales office in Beijing, China, to capitalize on the growing In Vitro Fertilization (IVF) market. It details the rationale, quotes management, and provides company background. This type of announcement, which is not a formal financial report (like 10-K, IR, ER) nor a specific regulatory filing about insider trading (DIRS) or capital changes (CAP/SHA), best fits the general category for corporate news releases that don't fit elsewhere. Given the options, 'Regulatory Filings' (RNS) serves as the best fallback for general corporate announcements that are not explicitly defined elsewhere, although it is primarily a business update. Since it is a press release announcing a strategic move rather than a financial result or mandatory disclosure, RNS is the most appropriate general classification.
2009-04-01 English
Regulatory Filings 2009
Regulatory Filings Classification · 95% confidence The document is a press release dated April 1, 2009, announcing the establishment of a sales organization in Beijing, China, to expand market presence. This announcement details a strategic business decision and operational expansion, rather than reporting financial results (ER/IR), providing audit details (AR), announcing management changes (MANG), or detailing insider trading (DIRS). It is a general corporate announcement regarding business strategy and market development. Since it is a press release announcing a significant business development that doesn't fit the specific categories like M&A (TAR), Capital Change (CAP/SHA), or Dividend (DIV), it falls best under the general regulatory announcement category, RNS, as a fallback for significant, non-financial, non-governance news releases.
2009-04-01 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.